Options·May 20, 2026·8 min read

How I Use Cash-Secured Puts to Buy Stocks at a Discount

Price · 12MYahoo Finance ↗

The cash-secured put is one of the most misunderstood strategies in options trading. Most traders think of it as a way to "get paid to wait." That framing is mostly right, but it misses the key mechanic: a cash-secured put is a conditional buy order that pays you while you wait for the right price.

I use it systematically in three scenarios. Here's exactly how.

Three Scenarios Where I Use Cash-Secured Puts

Scenario 1: Stock I Want, But It's Slightly Overvalued

The most common scenario. I've done my research on a company — strong balance sheet, accelerating revenue, management I trust. The stock is at $215. My analysis says fair value is $195-200. I'm not going to chase it at $215.

Instead of placing a limit order at $200 and waiting, I sell a put option. I collect premium while I wait. If the stock drops to $200, I get assigned — I buy the stock at $200, minus the premium I collected. My effective cost basis is below $200. Better than a limit order.

If the stock never drops to $200, I keep the premium and reassess. I'm being paid to wait.

Scenario 2: Post-Earnings Elevated IV

After a company reports earnings, IV drops sharply — "IV crush." But it doesn't always collapse all the way back to baseline immediately. In the 1–3 days after a report, IV is often still elevated 15–25% above pre-earnings levels.

This creates a short window where I can sell puts with more premium than usual. I specifically look for companies that reported in-line or slightly above expectations (not blowout beats, which send the stock surging — I might chase a better entry) but where the stock didn't move dramatically. Steady as-you-go reporters.

Post-earnings CSPs work best when: the company guided inline or above consensus, the stock moved less than the implied move (stayed range-bound), and IV is still elevated 2 days after the report.

Scenario 3: Oversold Technical Conditions

When a quality stock sells off sharply on market-wide pressure — not company-specific news — the combination of elevated IV and technically oversold conditions creates a strong CSP setup.

My criteria for "oversold": RSI below 35 on the daily chart, stock below the lower Bollinger Band (2σ), and the selloff is correlated with the broader market (SPX down 2%+ on the same day). I'm not trying to catch falling knives caused by fundamental deterioration. I'm capturing premium on temporary fear.

The AAPL Example: Walking Through the Numbers

February 2025. AAPL was trading at $215 following a strong quarter. I wanted to own AAPL below $200. The stock had been on a run and I didn't want to chase it at $215.

I sold the AAPL March 21 expiration $200 put for a premium of $3.20. This required me to set aside $20,000 in cash as collateral (the obligation to buy 100 shares at $200 if assigned).

Trade parameters:

  • Put sold: $200 strike, 30 DTE (from February 19)
  • Premium collected: $3.20 per share ($320 per contract)
  • Cash reserved: $20,000 (100 shares × $200)
  • Income yield: $320 / $20,000 = 1.6% in 30 days (annualized: 19.3%)

Two outcomes:

Outcome A — Put expires worthless (AAPL stays above $200): AAPL closes at $209 on March 21. My put expires worthless. I keep the $320 premium. Return: 1.6% in 30 days on $20,000 reserved capital. I reassess whether to sell another put or move on.

Outcome B — Assigned (AAPL falls below $200): AAPL drops to $194 by March 21. My $200 put is in the money. I am assigned — I buy 100 shares at $200.

My effective cost basis: $200 − $3.20 = $196.80 per share.

At a current market price of $194, I'm down $2.80 per share on paper — but I wanted to own AAPL below $200, and my effective cost is $196.80. I immediately look at selling a covered call. With AAPL at $194, I sell the April $200 call for $2.80. If AAPL recovers to $200, I sell my shares there plus keep the call premium: effective sale $202.80.

This is the wheel strategy in practice: CSP → assignment → covered call → repeat.

Annual Rate Math

Annualizing the CSP income is where the compounding math gets interesting.

From the AAPL example: 1.6% per month = 19.3% annualized, simple. If I'm running this on $20,000 of reserved capital and collecting 12 cycles of 30-day puts, the gross annualized income on that capital block is approximately $3,840 (12 × $320), before any assignment scenarios.

Compare this to just holding cash in a money market fund at ~4.8% — CSPs deliver roughly 4× the yield for the same capital, with the tradeoff being potential stock assignment (which I want anyway on the names I target).

Warning Signs: When I Don't Sell CSPs

I have three hard stops that prevent me from selling cash-secured puts regardless of premium attractiveness.

1. Downtrend on the daily chart. I don't sell puts on stocks in established downtrends. A downtrend means lower highs and lower lows on the daily timeframe over 3+ months. Premium is attractive because the stock is falling — that's not an opportunity, it's a value trap. I can identify downtrending stocks that recovered and broke their downtrend line, which I'll consider. But active downtrends: no.

2. High beta or event-driven volatility. Biotech stocks, small-cap speculative names, commodity producers with spot-price exposure — I avoid CSPs on these. The volatility that makes the premium attractive also makes the downside risk non-linear. A biotech can drop 60% on an FDA rejection. The $4.00 premium I collected doesn't cushion a $40 loss per share.

3. Earnings within 14 days. My 21-day rule for covered calls becomes a 14-day rule for CSPs. With 14 days to earnings, I'm selling an option that will experience IV crush in the wrong direction — the elevated premium collapses after the report regardless of outcome. I never want to sell a CSP and have it priced at $3.00 today and $0.80 tomorrow after an earnings report that moves the stock 5% against me. That's not a good trade.

The CSP is a tool for buying quality at better prices. Use it on quality.

Ruslan Averin, averin.com

Ruslan Averin is an independent investor and market analyst, author of averin.com, publishing market research since 2014.

A
Ruslan AverinInvestor & Market Analyst

Writes on capital allocation, risk, and market structure.